epilepsy. Episodic and paroxysmal disorders
Conditions
Interventions
Intervention 1: intervention group: patients with age 3-12 years receive 5cc of prepared extract(115 mg of extract is found in 5 cc of prepared drug) three times a day and patients with age >12 years
Treatment - Drugs
intervention group: patients with age 3-12 years receive 5cc of prepared extract(115 mg of extract is found in 5 cc of prepared drug) three times a day and patients with age >12 years receive 7.5 cc o
contorol group: patients with age 3-12 years receive 5cc of prepared placebo three times a day and patients with age >12 years receive 7.5 cc of prepared plasebo three times a day for two months. Then
Sponsors
Vice chancellor of Ahvaz Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Years to 18 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria : children with a diagnosis of refractory seizures; having at least two episodes of seizures during one month prior to study entry; regular consumption of previous antiepileptic drugs. Exclusion criteria ; occurrence of adverse side effects such as nausea and vomiting; increase the number and duration of seizure after starting NS and TV; and dissatisfaction to continue participation in study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Seizures frequency per week. Timepoint: two months prior to study-five months during study. Method of measurement: visitable seizure scaling.;Seizure duration. Timepoint: two months prior to study-five months during study. Method of measurement: visitable seizure scaling. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effets. Timepoint: five months. Method of measurement: visitable scaling. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Heydar Azadzaeh
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed